Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Acta Neuropathologica|August 9, 2022
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Acta Neuropathologica|August 9, 2022
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Pageof 14